Private company

Aberdeen Group plc

British Other Banking and Financial Services company based in Edinburgh. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersX0¹
Legal formCorporation

See how the biggest companies compare on our leaderboards

Corporate structure

Aberdeen Group plc is part of a group headed by J2 Global. 139 entities, 20 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

J2 Global Los Angeles, California, United States
- Aberdeen Group plc X0
  - Codexis Stake · Redwood City
  - Corbus Pharmaceuticals Stake · Norwood, Massachusetts, United States
  - Eloxx Pharmaceuticals, Inc. Stake · Bridgewater, New Jersey, United States
  - Equillium, Inc. Stake · LaJolla, California, United States
  - Freenome, Inc. Stake · South San Francisco, California, United States
  - IMMUNIC, INC. Stake · Wilmington, Delaware, United States
  - InspireMD, Inc. Stake · Boston, Massachusetts, United States
  - Precision BioSciences Stake · Durham, North Carolina, United States
  - ProQR Therapeutics N.V. Stake · P7
  - Quoin Pharmaceuticals Ltd. Stake · Ashburn, Virginia
  - SERA PROGNOSTICS, INC. Stake · Salt Lake City, Utah
  - SOUTHEAST AIRPORT GROUP Stake
  - Tectonic Therapeutic, Inc. Stake · Watertown, Massachusetts
  - The Shyft Group Stake · Charlotte, Michigan, United States
  - uniQure N.V. Stake
- IGN Subsidiary · San Francisco
  - IGN Germany Subsidiary
- StrongVPN Subsidiary
- 2.4 Family Marketing Limited Subsidiary · United Kingdom
- Aberdeen Market Intelligence France SAS Subsidiary · France
- Advanced Messaging Technologies, Inc. Subsidiary · Delaware, United States
- Arthur L. Davis Publishing Agency, Inc. Subsidiary · Iowa, United States
- AskMen Subsidiary
- BabyCenter, L.L.C. Subsidiary · Delaware, United States
- Castle Connolly Medical Ltd Subsidiary · Delaware, United States
- Cell Rebel AB Subsidiary · Sweden
- Cell Rebel Sociedad Limitada Subsidiary · Spain
- Cloak Holdings, LLC Subsidiary · Delaware, United States
- CNET Media, Inc. Subsidiary · Delaware, United States
- Demandshore Media Pvt. Ltd. Subsidiary · India
- Demandshore Solutions Pvt. Ltd. Subsidiary · India
- DW Prime Holdings, Inc. Subsidiary · Delaware, United States
- Ekahau Inc. Subsidiary · Delaware, United States
- Electric Mail (Ireland) Limited Subsidiary · Ireland
- emedia Communications, LLC Subsidiary · California, United States
- EVERYDAY HEALTH INDIA PRIVATE LIMITED Subsidiary · Mumbai, India
- Everyday Health Media, LLC Subsidiary · Delaware, United States
- Everyday Health, Inc. Subsidiary · Delaware, United States
- Excel Micro, LLC Subsidiary · Pennsylvania, United States
- Families Online Limited Subsidiary · United Kingdom
- and 97 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (15 companies). Each entity in the chart links to its source.

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

Chief Executive OfficerJason Michael Windsor named Apr 21, 2026²
Chief Financial OfficerSiobhan Geraldine Boylan named Apr 21, 2026²
Chief Executive OfficerJason Windsor named Nov 8, 2024 to Apr 28, 2025³
Chief Financial OfficerStephanie Bruce named Apr 25, 2022 to Apr 27, 2023⁴
Chief Executive OfficerStephen Bird named Apr 25, 2022 to Apr 27, 2023⁴
DirectorCarolyn Cathleen Raffaeli named Apr 21, 2026²
Chairman of the Board of DirectorsDouglas Jardine Flint named Apr 21, 2026²
DirectorHannah Melissa Wood Grove named Apr 21, 2026²
DirectorJohn Geraldine Devine named Apr 21, 2026²
DirectorJonathan Paul Asquith named Apr 21, 2026²
DirectorKate Paul Bickerstaffe named Apr 21, 2026²
DirectorVivek Gopaldas Ahuja named Apr 21, 2026²
DirectorCathi Raffaell named Nov 8, 2024 to Apr 28, 2025³
Chairman of the Board of DirectorsDouglas Flint named Apr 25, 2022 to Apr 28, 2025³
DirectorHannah Grove named Apr 25, 2022 to Apr 28, 2025³
DirectorJohn Devine named Apr 25, 2022 to Apr 28, 2025³
DirectorJonathan Asquith named Apr 25, 2022 to Apr 28, 2025³
DirectorKatie Bickerstaffe named Nov 8, 2024 to Apr 28, 2025³
DirectorMichael O'Brien named Apr 27, 2023 to Apr 28, 2025³
DirectorPam Kaur named Apr 27, 2023 to Apr 28, 2025³
DirectorVivek Ahuja named Nov 8, 2024 to Apr 28, 2025³
DirectorBrian McBride named Apr 25, 2022 to Apr 27, 2023⁴
DirectorCatherine Bradley named Apr 25, 2022 to Apr 27, 2023⁴
DirectorCathi Raffaeli named Apr 25, 2022 to Apr 27, 2023⁴
DirectorCecilia Reyes named Apr 25, 2022⁵
DirectorJutta af Rosenborg named Apr 25, 2022⁵
DirectorMartin Pike named Apr 25, 2022⁵

Filings

33 filings to the SEC since October 2021: 6 private raises, 27 other. The latest 20:

Jul 31, 202613F-HR EDGAR
Jul 24, 2026N-PX EDGAR
Apr 29, 202613F-HR EDGAR
Apr 21, 2026D EDGAR
Jan 16, 202613F-HR EDGAR
Nov 7, 202513F-HR EDGAR
Aug 15, 2025N-PX EDGAR
Jul 24, 202513F-HR EDGAR
May 13, 202513F-HR EDGAR
Apr 28, 2025D EDGAR
Jan 24, 202513F-HR EDGAR
Nov 8, 2024D/A EDGAR
Oct 25, 202413F-HR EDGAR
Aug 29, 2024N-PX EDGAR
Aug 9, 202413F-HR EDGAR
Jun 20, 202413F-HR/A EDGAR
Jun 20, 202413F-HR/A EDGAR
Jun 20, 202413F-HR/A EDGAR
May 9, 202413F-HR EDGAR
Apr 26, 2024D EDGAR

The 33 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Aberdeen Group plc has told the SEC it owns more than 5% of 15 companies, latest first (Schedules 13D and 13G).

ProQR Therapeutics N.V.SCHEDULE 13G Jul 29, 2026⁶
Eloxx Pharmaceuticals, Inc.SCHEDULE 13G Jul 27, 2026⁷
CodexisSCHEDULE 13G/A Jul 30, 2025 to Jul 20, 2026⁸
uniQure N.V.SCHEDULE 13G/A Jul 31, 2025 to Jul 20, 2026⁹
IMMUNIC, INC.SCHEDULE 13G/A Jul 31, 2025 to Jul 16, 2026¹⁰
SERA PROGNOSTICS, INC.SCHEDULE 13G/A Aug 5, 2025 to Jul 15, 2026¹¹
Equillium, Inc.SCHEDULE 13G May 7, 2026¹²
Quoin Pharmaceuticals Ltd.SCHEDULE 13G/A Jan 28, 2026 to Apr 29, 2026¹³
Freenome, Inc.SCHEDULE 13G Apr 28, 2026¹⁴
InspireMD, Inc.SCHEDULE 13G/A Nov 7, 2025 to Feb 2, 2026¹⁵
Tectonic Therapeutic, Inc.SCHEDULE 13G Jan 29, 2026¹⁶
Precision BioSciencesSCHEDULE 13G Jan 27, 2026¹⁷
Corbus PharmaceuticalsSCHEDULE 13G Jan 16, 2026¹⁸
The Shyft GroupSC 13G/A Jan 28, 2022 to Feb 2, 2024¹⁹
SOUTHEAST AIRPORT GROUPSC 13G/A Jan 28, 2022²⁰

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$18.2M 2022–2026

Private raises (Form D) $18.2M

Figures by year

Year	Private raises (Form D)	Total
2026	$6.5M	$6.5M
2025	$5.6M	$5.6M
2024	$5.1M	$5.1M
2023	$584.0K	$584.0K
2022	$464.0K	$464.0K

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

Apr 7, 2026Raised $6.5 million in a private offering of equity² Form D: 53 investors so far Form D
Apr 11, 2025Raised $5.6 million in a private offering of equity³ Form D: 45 investors so far Form D
Apr 8, 2024Raised $5.1 million in a private offering of equity²¹ Form D: 36 investors so far Form D
Apr 11, 2023Raised $584,045 in a private offering of equity⁴ Form D: 27 investors so far Form D
Apr 8, 2022Raised $464,017 in a private offering of equity⁵ Form D: 70 investors so far Form D

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAberdeen Group plc filings on SEC EDGAR
2
SEC EDGARAberdeen Group plc Form D naming Jason Michael Windsor
3
SEC EDGARAberdeen Group plc Form D naming Jason Windsor
4
SEC EDGARAberdeen Group plc Form D naming Stephanie Bruce
5
SEC EDGARAberdeen Group plc Form D naming Cecilia Reyes
6
SEC EDGARAberdeen Group plc SCHEDULE 13G on ProQR Therapeutics N.V.
7
SEC EDGARAberdeen Group plc SCHEDULE 13G on Eloxx Pharmaceuticals, Inc.
8
SEC EDGARAberdeen Group plc SCHEDULE 13G/A on Codexis
9
SEC EDGARAberdeen Group plc SCHEDULE 13G/A on uniQure N.V.
10
SEC EDGARAberdeen Group plc SCHEDULE 13G/A on IMMUNIC, INC.
11
SEC EDGARAberdeen Group plc SCHEDULE 13G/A on SERA PROGNOSTICS, INC.
12
SEC EDGARAberdeen Group plc SCHEDULE 13G on Equillium, Inc.
13
SEC EDGARAberdeen Group plc SCHEDULE 13G/A on Quoin Pharmaceuticals Ltd.
14
SEC EDGARAberdeen Group plc SCHEDULE 13G on Freenome, Inc.
15
SEC EDGARAberdeen Group plc SCHEDULE 13G/A on InspireMD, Inc.
16
SEC EDGARAberdeen Group plc SCHEDULE 13G on Tectonic Therapeutic, Inc.
17
SEC EDGARAberdeen Group plc SCHEDULE 13G on Precision BioSciences
18
SEC EDGARAberdeen Group plc SCHEDULE 13G on Corbus Pharmaceuticals
19
SEC EDGARAberdeen Group plc SC 13G/A on The Shyft Group
20
SEC EDGARAberdeen Group plc SC 13G/A on SOUTHEAST AIRPORT GROUP
21
SEC EDGARForm D: Raised $5.1 million in a private offering of equity